Wall Street was poised for a lower on Friday after earnings from Google failed to meet heightened expectations as GE and Bank of America reported quarterly results.

Google Inc , the Internet search giant, reported a 23 percent jump in quarterly revenue on a rebound in Web advertising, but the stock dropped 4.9 percent to $566.13 in premarket trading as the results disappointed some investors who looked for blowout results.

Bank of America Corp added 0.1 percent to $19.49 premarket after the largest U.S. bank by assets reported higher-than-expected earnings, but the bank said loan demand remained low.

We would have had a much bigger reaction if the numbers were bad and given people an excuse to take profits, said Frank Lesh, a futures analyst and broker at FuturePath Trading LLC in Chicago. It just serves us to hold in here.

General Electric Co shed 0.2 percent to $19.47 as quarterly revenues were lowered than expected and new equipment orders were down, even as it reported a profit that was higher than estimates.

GE is like a mini corporate America when you think of all the things that they touch. When you can get this sort of nice clean report, it's a pretty good signal that earnings season should be better than expected this first quarter, said Arthur Hogan, chief market analyst at Jefferies & Co in Boston.

S&P 500 futures shed 5.5 points and were below fair value, a formula that evaluates pricing by taking into account interest rates, dividends and time to expiration on the contract. Dow Jones industrial average futures lost 19 points, and Nasdaq 100 futures dropped 7.5 points.

U.S. housing starts rose more than expected in March to their highest level since November 2008 and permits to build new homes hit a 17-month high, the Commerce Department said.

Mattel Inc gained 3.8 percent to $24.65 after the No. 1 toymaker surprised Wall Street with a quarterly profit versus a year-ago loss on strong demand in both its classic and newer products.

Phase Forward Inc
soared 29 percent to $16.87 after the maker of drug data management software agreed to be acquired by Oracle Corp for $17 a share. Oracle shed 0.4 percent to $26.10 premarket.

Boston Scientific Corp climbed 5.3 percent to $7.52 after the company said it is resuming U.S. shipments of most of its implanted defibrillators after regulators cleared manufacturing changes.

The University of Michigan sentiment data for April is expected shortly after the market open.

(Reporting by Chuck Mikolajczak; additional reporting by Edward Krudy; editing by Jeffrey Benkoe)